Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Seeley TW"'
Publikováno v:
Hypoxia, Vol Volume 5, Pp 1-9 (2017)
Todd W Seeley,Mark D Sternlicht, Stephen J Klaus,Thomas B Neff,David Y Liu Therapeutics R&D, FibroGen, Inc., San Francisco, CA, USA Abstract: The effects of pharmacological hypoxia-inducible factor (HIF) stabilization were investigated in the MMTV-Ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::87040ca4ba083985d5f563c7a3a3efeb
https://www.dovepress.com/induction--of-erythropoiesis-by-hypoxia-inducible-factor-prolyl-hydrox-peer-reviewed-article-HP
https://www.dovepress.com/induction--of-erythropoiesis-by-hypoxia-inducible-factor-prolyl-hydrox-peer-reviewed-article-HP
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Del Balzo U; FibroGen, Inc., San Francisco, California udelbalzo@fibrogen.com., Signore PE; FibroGen, Inc., San Francisco, California., Walkinshaw G; FibroGen, Inc., San Francisco, California., Seeley TW; FibroGen, Inc., San Francisco, California., Brenner MC; FibroGen, Inc., San Francisco, California., Wang Q; FibroGen, Inc., San Francisco, California., Guo G; FibroGen, Inc., San Francisco, California., Arend MP; FibroGen, Inc., San Francisco, California., Flippin LA; FibroGen, Inc., San Francisco, California., Chow FA; FibroGen, Inc., San Francisco, California., Gervasi DC; FibroGen, Inc., San Francisco, California., Kjaergaard CH; FibroGen, Inc., San Francisco, California., Langsetmo I; FibroGen, Inc., San Francisco, California., Guenzler V; FibroGen, Inc., San Francisco, California., Liu DY; FibroGen, Inc., San Francisco, California., Klaus SJ; FibroGen, Inc., San Francisco, California., Lin A; FibroGen, Inc., San Francisco, California udelbalzo@fibrogen.com., Neff TB; FibroGen, Inc., San Francisco, California.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Aug; Vol. 374 (2), pp. 342-353. Date of Electronic Publication: 2020 Jun 02.
Autor:
Vainio LE; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland., Szabó Z; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland., Lin R; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland., Ulvila J; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland., Yrjölä R; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland., Alakoski T; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland., Piuhola J; Division of Cardiology, Department of Internal Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland., Koch WJ; Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Ruskoaho H; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Fouse SD; FibroGen, Inc., San Francisco, California., Seeley TW; FibroGen, Inc., San Francisco, California., Gao E; Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania., Signore P; FibroGen, Inc., San Francisco, California., Lipson KE; FibroGen, Inc., San Francisco, California., Magga J; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland., Kerkelä R; Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Publikováno v:
JACC. Basic to translational science [JACC Basic Transl Sci] 2019 Feb 25; Vol. 4 (1), pp. 83-94. Date of Electronic Publication: 2019 Feb 25 (Print Publication: 2019).
Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab.
Autor:
Sternlicht MD; FibroGen, Inc., San Francisco, USA., Wirkner U; Department of Translational Radiooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bickelhaupt S; Department of Radiology, DKFZ, Heidelberg, Germany., Lopez Perez R; Department of Molecular and Radiation Oncology, DKFZ, Heidelberg, Germany., Tietz A; Department of Molecular and Radiation Oncology, DKFZ, Heidelberg, Germany., Lipson KE; FibroGen, Inc., San Francisco, USA. klipson@fibrogen.com., Seeley TW; FibroGen, Inc., San Francisco, USA., Huber PE; Department of Molecular and Radiation Oncology, DKFZ, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Center, Heidelberg, Germany.
Publikováno v:
Respiratory research [Respir Res] 2018 Jan 18; Vol. 19 (1), pp. 14. Date of Electronic Publication: 2018 Jan 18.
Autor:
Bickelhaupt S; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Departments of Radiation Oncology, University Hospital Center, Heidelberg, Germany., Erbel C; Departments of Cardiology, University Hospital Center, Heidelberg, Germany., Timke C; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Departments of Radiation Oncology, University Hospital Center, Heidelberg, Germany., Wirkner U; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Dadrich M; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Flechsig P; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Tietz A; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pföhler J; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Gross W; Departments of Experimental Surgery, University Hospital Center, Heidelberg, Germany., Peschke P; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hoeltgen L; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Katus HA; Departments of Cardiology, University Hospital Center, Heidelberg, Germany., Gröne HJ; Departments of Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Nicolay NH; Departments of Radiation Oncology, University Hospital Center, Heidelberg, Germany., Saffrich R; Departments of Hematology and Oncology, University Hospital Center, Heidelberg, Germany., Debus J; Departments of Radiation Oncology, University Hospital Center, Heidelberg, Germany., Sternlicht MD; Departments of Molecular Biology, FibroGen, Inc., San Francisco, CA, USA., Seeley TW; Departments of Molecular Biology, FibroGen, Inc., San Francisco, CA, USA., Lipson KE; Drug Research, FibroGen, Inc., San Francisco, CA, USA., Huber PE; Departments of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Departments of Radiation Oncology, University Hospital Center, Heidelberg, Germany.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2017 Aug 01; Vol. 109 (8).
Autor:
Koshman YE; The Cardiovascular Research Institute, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, United States., Sternlicht MD; FibroGen, Inc., San Francisco, CA 94158, United States., Kim T; The Cardiovascular Research Institute, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, United States., O'Hara CP; The Cardiovascular Research Institute, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, United States., Koczor CA; Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, United States., Lewis W; Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, United States., Seeley TW; FibroGen, Inc., San Francisco, CA 94158, United States., Lipson KE; FibroGen, Inc., San Francisco, CA 94158, United States., Samarel AM; The Cardiovascular Research Institute, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, United States. Electronic address: asamare@luc.edu.
Publikováno v:
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2015 Dec; Vol. 89 (Pt B), pp. 214-22. Date of Electronic Publication: 2015 Nov 05.
Autor:
Neesse A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom., Frese KK, Bapiro TE, Nakagawa T, Sternlicht MD, Seeley TW, Pilarsky C, Jodrell DI, Spong SM, Tuveson DA
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2013 Jul 23; Vol. 110 (30), pp. 12325-30. Date of Electronic Publication: 2013 Jul 08.